focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Cyclicals bet: Autos on a high

Mon, 07th Sep 2020 11:38

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com)
and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Danilo Masoni
(danilo.masoni@thomsonreuters.com) and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in
Milan.

CYCLICALS BET: AUTOS ON A HIGH (1038 GMT)

One sector in Europe is standing out this morning: it's autos.

While the region is showing a quite broad-based rebound, the STOXX Auto index is the
only one that has actually managed to break new ground, up over 2.3% at one point to its highest
since February 2020.

Why that? There's an ongoing "cyclicals bet", as one trader points out, and the tech rout
we've witnessed last week could add fuel to a rotation into the battered end of the market.

Autos are among the worst performers in Europe this year, down around 14%. So there's room
to catch up.

But there's also some good-looking newsflow out of Germany with a Volkswagen
executive telling Welt am Sonntag in an interview published yesterday that VW is in a position
to overtake Tesla in terms of e-car manufacturing by 2023.

That's "positive for sentiment", another trader notes.

(Danilo Masoni)

****

HERE ARE THE WINNERS OF POSITIVE VACCINE NEWS (1010 GMT)

Positive vaccine developments are probably propping up market sentiment today and protecting
global stocks from the U.S. tech selloff and concerns over Softbank's derivatives exposure.

UBS has taken a deeper look and has singled out the potential impact of a Covid vaccine on
European equity markets.

Among countries, Germany is the most affected, followed by the Scandinavian markets and
France, in a ranking that fits with their broader cyclical exposure and their performance since
the market low in March, a UBS research note says.

In sectors, the deep cyclicals and the parts of the market most affected by mobility
restrictions (Transport and Energy) are most sensitive, while banks have failed to get any
benefit and have lagged behind in terms of relative performance since the market low, it adds.

Transport, Tech Hardware and Semis have all outperformed more since the market low than
their beta to vaccine news would suggest.

(Stefano Rebaudo)

*****

OPENING SNAPSHOT: IN POSITIVE TERRITORY, BANKS FLAT (0756 GMT)

European stocks open higher and hold their ground in positive territory despite a fresh
selloff on U.S. tech stocks on Friday continues to worry investors globally.

The STOXX 600 is up 0.9%, in what seems a straight risk-on session with cyclicals
leading gains. The auto sector leads sectoral gains up 1.9%, followed by real estate
up 1.7% and industrial goods and services up 1.4%. The euro Stoxx volatility
index is down almost 3 points at 28.7.

Spain’s banking index turns negative after opening up around 2.7%, while the
European index is flat, after last week rally on M&A negotiations between Bankia
and Caixabank.

Dechra stocks are up 5.9% after its profit beat expectations.

U.S. markets will be closed today for the Labour Day holiday.

SoftBank Group closed down 7% as the conglomerate's bets on equity derivatives tied
to listed technology companies made investors uncomfortable.

(Stefano Rebaudo)

*****

ON THE RADAR: VACCINE DEVELOPMENTS, AB FOODS (0641 GMT)

European stocks are set to open higher as worries about a U.S. tech selloff eased after the
Nasdaq on Friday closed lower but well above its session low with Apple scoring a tiny gain for
the day.

More news on the vaccine front with Australia expecting to receive its first batches after a
deal struck with CSL to manufacture two vaccines - one developed by rival AstraZeneca
and Oxford University, and another developed in CSL's own labs with the University of
Queensland.

Meanwhile Sanofi's chief in France said a vaccine that Sanofi is developing with
Britain's GlaxoSmithKline was likely to be priced at less than 10 euros.

Associated British Foods expects full-year profit at its Primark fashion chain to be
at least at the top end of its previously guided range after trading in its latest quarter
exceeded expectations.

Italy's Treasury wants to find a buyer for Monte dei Paschi di Siena by the end of
the year to help the bailed-out bank to clean up its remaining problem loans.

Italy is close to reaching an agreement over the future of Atlantia unit Autostrade
per l'Italia, Prime Minister Giuseppe Conte said on Saturday in an interview. Progress has been
slowed recently by difficulties in agreeing a valuation for the unit with state lender Cassa
Depositi e Prestiti (CDP), which is due to take control of Autostrade.

Ryanair boss Michael O'Leary's proposed 458,000 euro annual bonus came under fire on
Friday, as an influential investor advisory firm urged shareholders to oppose the package.

(Stefano Rebaudo)

*****

MORNING CALL: IN THE BLACK DESPITE U.S. TECH LOWER (0533 GMT)

European stock futures are in the black despite a new selloff in tech shares on Wall Street
on Friday and Asian stocks on their back foot worried about high valuations.

The Nasdaq on Friday closed lower but well above its session low as selling eased late in
the session, with mega-cap tech companies paring losses though only Apple managed a
tiny gain for the day.

Investors are still uncertain about whether the U.S. is staging just some profit taking or a
massive risk-off move is on its way.

Some traders said a pile of red flags was building up, while mentioning Softbank. Its shares
fell 7% following media reports that the conglomerate made big bets on equity derivatives tied
to listed tech companies.

(Stefano Rebaudo)

*****

More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.